Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank - Test2 - elhamkhani - TriplyDB

Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank

Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank

http://www.wikidata.org/entity/Q36287896

about

Brain oscillations in bipolar disorder and lithium-induced changes Serotonin, neural markers, and memory Theranostic Biomarkers for Schizophrenia An Audit of Indian Health Insurance Claims for Mental Illness from Pooled Insurance Information Bureau's Macroindicator Data Challenges and developments in research of the early stages of bipolar disorder.Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression.The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.Personalized medicine in psychiatry.Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience.Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.Editorial: 5-HT2A/2B/2C Receptors, Memory, and Neuropsychiatric Disorders.Predictive analytics in mental health: applications, guidelines, challenges and perspectives.Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.Biomarkers for Major Depressive Disorder: Economic Considerations.Searching biomarkers for mental disorders-lessons from Alzheimer's disease.Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects.Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia.Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis.Behavioural biomarkers and mobile mental health: a new paradigm

P2860

Q26750446-0DE41850-F417-4F32-AD7A-35650E351512 Q26800204-95832F02-6E07-4CA1-9D68-CEFEF2C79BE8 Q33624412-FB734293-9B46-4BC5-928D-DD90D84E3994 Q33771992-034C1370-BC9A-4507-9E67-C2934C139DBF Q36105891-CCE25535-7AF0-4A88-B58C-CA4EB5EAB0BF Q36813765-9A907526-F35B-46F8-A8E9-9A9644BEE426 Q38634678-D9E0A8A3-54F4-43DB-8622-05A3AA95B3CD Q38671559-75E09B51-D71F-4AC0-89C9-DED59FA96761 Q38937776-B7BC0141-E72A-430F-8C1F-5BEFA5CFADEE Q39220718-F49CB8BF-214D-4DF5-9022-58DCDC75E745 Q40058836-08E40857-1790-4226-B20B-035A3ED15566 Q42174497-B9CAD052-82AC-47E2-8476-010CE9FDE533 Q45939317-5733606E-6DD4-4BE1-99C5-0BCB3DF08574 Q47239298-D14B5BE6-B996-44D4-BB05-BFEAA773FCBC Q47671635-27654601-66A5-4E81-A32F-FB5CF3A778C8 Q47928238-1B9D2D3C-72D9-4998-BFB2-C83E438974DE Q48691999-DC4B2977-17BB-4533-B1F2-B760F67BD668 Q52320951-952479AE-4FB1-46F4-9B0F-75A1927ACE71 Q52645804-8A02B302-DE5B-4308-8F88-93B97BC8834A Q57612212-09B26AB0-D398-4C74-8F20-5ACFD42A5120

P2860

Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank

http://www.wikidata.org/entity/Q36287896

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Biomarkers for Psychiatry: The ...... rt of the 2013 CINP Think Tank

@ast

Biomarkers for Psychiatry: The ...... rt of the 2013 CINP Think Tank

@en

type

label

Biomarkers for Psychiatry: The ...... rt of the 2013 CINP Think Tank

@ast

Biomarkers for Psychiatry: The ...... rt of the 2013 CINP Think Tank

@en

prefLabel

Biomarkers for Psychiatry: The ...... rt of the 2013 CINP Think Tank

@ast

Biomarkers for Psychiatry: The ...... rt of the 2013 CINP Think Tank

@en

P1433

Q36287896-DA3744E1-95D6-4AC2-8811-8A3EAA1A7F16

P1476

Q36287896-1D8F0FFE-E74D-45EA-A393-031B32A6985F

P2093

Q36287896-22B177DC-043F-476C-8D5B-70D6F81AAEDC

Q36287896-2DF20D1E-9280-47AB-8D40-A022790776C6

Q36287896-4A27DF4E-0F1E-4C3C-BAB2-E604AA16603E

Q36287896-E0403DFD-FB2A-49D6-A945-9B0A7FACFC11

Q36287896-F662A5EE-1717-45D3-A1CD-5D7B2CBC96B8

Q36287896-F9584FC6-E137-4F9D-9618-A2E2D1B97D90

P2860

Q36287896-01DFDDAB-65F3-4E44-87E9-B201A2AED82F

Q36287896-02DC1C27-D557-43DC-9BBE-820A1EBEC847

Q36287896-0561639B-B777-408A-8EE0-432C511D726A

Q36287896-0EA2E763-C396-4F2A-B1BC-4C2F0A6B967D

Q36287896-1411D387-A7C6-4984-9B74-F60FCE5D2368

Q36287896-1780ED65-1074-436F-937A-1C97D17F3032

Q36287896-1D85B2D8-50AE-48AE-83A9-99A3D942AE5B

Q36287896-1EAE5EA3-4C64-43DB-85B8-D8BAA26B8B01

Q36287896-1FB114B2-8DC3-43AA-AA0B-60361416F9CB

Q36287896-233A17AE-B3D0-4F3D-88B1-2C437AD804A7

P304

Q36287896-5DE6C6D6-3326-4387-9BD1-5B0189BB2614

P31

Q36287896-A136A02A-24E8-40A1-BA22-EB20813AAA15

P356

Q36287896-D5CDA341-B826-4CFA-ADCA-407BE3B392A3

P433

Q36287896-9C2EF8A2-8BCA-4602-97B2-78F1C84E9A17

P478

Q36287896-68E53F32-83F5-40CA-A9B9-ACC248734732

P50

Q36287896-16C734EB-FA28-4A89-856A-877509BE74DE

Q36287896-A61A2BAD-A42B-49D2-8263-858E1555E02F

P577

Q36287896-3F28779D-44CA-48F7-A5AE-A6A8F6594FC3

P5875

Q36287896-54D8D18E-7C4C-4763-A95C-A473BD69BC7C

P698

Q36287896-3F97A266-9AA3-4CB6-A6B8-CAC0A46553D1

P921

Q36287896-11986F5B-2AC7-42E0-8CCF-9A09A9CD061C

Q36287896-35502DCC-38D3-4175-9348-64A62D8D3C49

P932

Q36287896-90F1E9A2-68C7-4886-8FAC-2C990D8ACD19

P356

P1433

The International Journal of Neuropsychopharmacology

P1476

Biomarkers for Psychiatry: The ...... rt of the 2013 CINP Think Tank

@en

P2093

Brian Dean

http://www.w3.org/2001/XMLSchema#string

Christoph W Turck

http://www.w3.org/2001/XMLSchema#string

Elizabeth Scarr

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Möller

http://www.w3.org/2001/XMLSchema#string

Mark J Millan

http://www.w3.org/2001/XMLSchema#string

Shitij Kapur

http://www.w3.org/2001/XMLSchema#string

P2860

Psychological effect of genetic testing for Huntington's disease: an update of the literature.

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis

Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition

SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties.

Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification.

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.

P304

pyv042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/IJNP/PYV042

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Bertolino

P577

2015-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275363288

http://www.w3.org/2001/XMLSchema#string

P698

25899066

http://www.w3.org/2001/XMLSchema#string

P921

P932

4648162

http://www.w3.org/2001/XMLSchema#string